A series of potential therapeutic targets were identified through our comprehensive analysis of common DEGs in multiple cancer types and drug-response data, such as the “core nodes” in Fig. 6B, like ASAP2, APP, and ACTN1, whose expression level were found to be significantly correlated to cell’s response to several different anti-cancer drugs targeting different pathways. Here, APP is linked to cancer.